Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Sites / Centers for Disease Control / Gurbaxani, Brian

Gurbaxani, Brian (Ph.D.)

Investigator, Centers for Disease Control, 404-639-3699

Contact Information

Fax:
Co-Investigator
Biostatistics

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Clinical Validation of Molecular Signatures of Cervical Neoplasia 0 0
Development of FISH-based assay for early detection of high grade cervical dysplasia 0 0
Identification of New Markers in Normal and Abnormal Pap Smears 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
EDRN Resource Network Exchange 0 0

Publications

Publication Name PubMed ID Journal
Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. 17045346 J. Virol. Methods
Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells. 17301262 Cancer Epidemiol. Biomarkers Prev.
Bioelectronic DNA detection of human papillomaviruses using eSensor: a model system for detection of multiple pathogens. 12814521 BMC Infect. Dis.
Global amplification of sense RNA: a novel method to replicate and archive mRNA for gene expression analysis. 13679029 Genomics
Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. 15006929 Cancer Epidemiol. Biomarkers Prev.
Impact of RNA extraction from limited samples on microarray results. 14628670 BioTechniques
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. 15688414 Int. J. Cancer
DNA and RNA references for qRT-PCR assays in exfoliated cervical cells. 16436642 J Mol Diagn
Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study. 16229879 Gynecol. Oncol.
Molecular markers for early detection of cervical neoplasia. 15322318 Dis. Markers
Gene expression profiling of dysplastic differentiation in cervical epithelial cells harboring human papillomavirus 16. 15885499 Genomics
Effect of storage temperatures on the stability of cytokines in cervical mucous. 17449271 Cytokine
Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III. 15598773 Cancer Epidemiol. Biomarkers Prev.
Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery. 15876354 BMC Genomics
Characterization of the Human Cervical Mucous Proteome. 20461121 Clin Proteomics
Psychosocial factors in risk of cervical intraepithelial lesions. 19361319 J Womens Health (Larchmt)
Optimization of SELDI-TOF protein profiling for analysis of cervical mucous. 19064004 J Proteomics

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

1600 Clifton Road, MS A15
CDC

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

32nd SC Meeting
Thank you to everyone who made the 32nd EDRN Steering Committee meeting a success. The next event is the 10th EDRN Scientific Workshop from March 6-8, 2018 in Bethesda, MD. More information about this Workshop will be sent soon. Click here to view the flyer.
EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.